About Javeri Equity Derivatives Mutual Funds IPO Corporate Info Research Contact Us
Mutual Funds
Mutual Funds
Fund Profile
Scheme Profile
Daily NAV
Historical NAV
Category Returns
Dividend Details
Fund Ranking
MF Activities
All Holdings
What's In / What's Out
MF Trends
MF Tools
  Home   >   MUTUAL FUND  >  MUTUAL FUNDS  >  CATEGORY RETURNS
CATEGORY RETURNS      
AMC : Category : Scheme :
Quant Healthcare Fund-Reg(G)
TypeInvestment In% of NAVNo. of sharesValue (Rs cr)
Domestic EquitiesAster DM Healthcare Limited10.371962676539.2950
Domestic EquitiesRPG Life Sciences Limited8.876915052933.6312
Domestic EquitiesZydus Wellness Ltd7.744264173029.3399
Domestic EquitiesSequent Scientific Limited7.2632147712627.5174
Domestic EquitiesANTHEM BIOSCIENCES LIMITED6.701733355425.3901
Domestic EquitiesPfizer Ltd6.37434795424.1496
Domestic EquitiesAurobindo Pharma Limited6.216821730023.5531
Domestic EquitiesAlivus Life Sciences6.040424629822.8848
Domestic EquitiesHDFC Life Insurance Co Ltd5.938129740622.4973
Domestic EquitiesSMS Pharmaceuticals Limited5.402783321320.4687
Domestic EquitiesConcord Biotech Limited3.63038347213.7537
Domestic EquitiesSun Pharmaceutical Industries Limited3.25077724912.3158
Domestic EquitiesLupin Limited2.87435697610.8898
Domestic EquitiesGland Pharma Limited1.4759280765.5916
Total 82.1614 311.2780
Cash & Cash Equivalents and Net AssetsTREPS 01-Oct-2025 DEPO 1013.60795155551.5551
Cash & Cash Equivalents and Net AssetsNCA-NET CURRENT ASSETS-12.4019 -46.9862
Total 1.2060 4.5689
Treasury Bills91 Days Treasury Bill 18-Dec-20251.82667000006.9201
Treasury Bills91 Days Treasury Bill 20-Nov-20250.78603000002.9779
Treasury Bills91 Days Treasury Bill 28-Nov-20250.78503000002.9742
Treasury Bills91 Days Treasury Bill 04-Dec-20250.78443000002.9717
Total 4.1820 15.8439
Derivatives-FuturesLupin Limited 28/10/20256.677813132525.2998
Derivatives-FuturesSun Pharmaceutical Industries Limited 28/10/20253.08527280011.6888
Derivatives-FuturesAurobindo Pharma Limited 28/10/20252.68769350010.1822
Total 12.4507 47.1708
 
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.